<--- Back to Details
First PageDocument Content
Glucogenic amino acids / Ketogenic amino acids / Proteinogenic amino acids / Mental retardation / Phenylketonuria / Phenylalanine / Aspartame / Tyrosine / Protein / Chemistry / Organic chemistry / Aromatic amino acids
Date: 2009-03-18 18:56:23
Glucogenic amino acids
Ketogenic amino acids
Proteinogenic amino acids
Mental retardation
Phenylketonuria
Phenylalanine
Aspartame
Tyrosine
Protein
Chemistry
Organic chemistry
Aromatic amino acids

Phenylketonuria (PKU) Phenylketonuria is a genetic disorder that is characterized by a person’s inability to utilize the essential amino acid, phenylalanine. A person with PKU lacks the enzyme phenylalanine hydroxylase

Add to Reading List

Source URL: www.sde.idaho.gov

Download Document from Source Website

File Size: 16,00 KB

Share Document on Facebook

Similar Documents

A second-generation expression system for tyrosine-sulfated proteins and its application in crop protection

A second-generation expression system for tyrosine-sulfated proteins and its application in crop protection

DocID: 1uOgH - View Document

UNDERSTANDING IN VIVO ROLES OF ELKS IN INNATE IMMUNITY Identification of ELKS gene In papillary thyroid carcinoma tissue samples of Japanese patients, tyrosine kinase domain of proto-oncogene RET was found to be fused to

UNDERSTANDING IN VIVO ROLES OF ELKS IN INNATE IMMUNITY Identification of ELKS gene In papillary thyroid carcinoma tissue samples of Japanese patients, tyrosine kinase domain of proto-oncogene RET was found to be fused to

DocID: 1sBYn - View Document

HEP Internship project 3: Unraveling the function of band 3 “tyrosine” phosphorylation during erythropoiesis and in erythrocytes. Introduction: Erythropoiesis is a process occurring in the bone marrow which end point

HEP Internship project 3: Unraveling the function of band 3 “tyrosine” phosphorylation during erythropoiesis and in erythrocytes. Introduction: Erythropoiesis is a process occurring in the bone marrow which end point

DocID: 1rSlW - View Document

SUPPLEMENTARY	
  INFORMATION:	
  Specificity	
  and	
  mechanism-­‐ of-­‐action	
  of	
  the	
  JAK2	
  tyrosine	
  kinase	
  inhibitors	
  ruxolitinib	
  and	
   SAR302503	
  (TG101348)	
   1. Deter

SUPPLEMENTARY  INFORMATION:  Specificity  and  mechanism-­‐ of-­‐action  of  the  JAK2  tyrosine  kinase  inhibitors  ruxolitinib  and   SAR302503  (TG101348)   1. Deter

DocID: 1rQNF - View Document

Cytoplasmic Tyrosine Kinases SRC, YES, FYN, LYN, LCK, BLK, HCK, FGR, YRK  SH3 SH2

Cytoplasmic Tyrosine Kinases SRC, YES, FYN, LYN, LCK, BLK, HCK, FGR, YRK SH3 SH2

DocID: 1rO3r - View Document